HCA Healthcare (NYSE: HCA) lifts commercial paper limit to $8.0B
Rhea-AI Filing Summary
HCA Inc., a direct wholly owned subsidiary of HCA Healthcare, Inc., increased the maximum size of its commercial paper program on July 29, 2026. The program’s aggregate face or principal amount outstanding at any time was raised from $4.0 billion to $8.0 billion.
The unsecured commercial paper notes issued under this program are unconditionally guaranteed by HCA Healthcare, Inc., and all other terms of the program remain unchanged. The notes and related guarantee are not registered under the Securities Act of 1933 and may be offered or sold in the United States only pursuant to an applicable exemption.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 2.03, 8.01
2 items
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
New commercial paper program limit: $8.0 billion
Previous commercial paper program limit: $4.0 billion
Common stock par value: $.01 per share
3 metrics
New commercial paper program limit
$8.0 billion
Maximum aggregate face or principal amount outstanding at any time
Previous commercial paper program limit
$4.0 billion
Prior maximum aggregate face or principal amount outstanding at any time
Common stock par value
$.01 per share
Par value of HCA Healthcare, Inc. common stock listed on NYSE
Key Terms
commercial paper program, unsecured commercial paper notes, unconditionally guaranteed, Securities Act of 1933
4 terms
commercial paper program financial
"increased the size of its commercial paper program under which the Issuer may issue"
A commercial paper program is a formal way a company issues very short-term IOUs to raise quick cash, typically for days to months, without using a bank loan. Investors care because it shows how the company manages short-term funding and how trustworthy it appears—like watching whether someone keeps using and repaying a credit card; frequent use or higher costs can signal cash strain, while smooth issuance suggests healthy liquidity.
unsecured commercial paper notes financial
"under which the Issuer may issue unsecured commercial paper notes (the “Notes”)"
unconditionally guaranteed financial
"The Notes are unconditionally guaranteed by the Parent Guarantor"
Securities Act of 1933 regulatory
"have not been and will not be registered under the Securities Act of 1933"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did HCA Healthcare (HCA) change in its commercial paper program?
On July 29, 2026, HCA Inc. increased its commercial paper program’s maximum aggregate face or principal amount outstanding from $4.0 billion to $8.0 billion. All other terms of the program remain as previously described by the company.
What is the new maximum amount under HCA (HCA) commercial paper program?
The program now allows up to $8.0 billion aggregate face or principal amount of unsecured commercial paper notes outstanding at any time. This is an increase from the prior maximum of $4.0 billion outstanding at any time.
Who guarantees the commercial paper notes issued by HCA Inc. (HCA)?
The unsecured commercial paper notes are unconditionally guaranteed by HCA Healthcare, Inc., acting as the Parent Guarantor. This guarantee applies to the notes issued under the expanded commercial paper program up to the new $8.0 billion limit.
Are HCA (HCA) commercial paper notes registered under the Securities Act of 1933?
No. The notes and the related guarantee have not been and will not be registered under the Securities Act of 1933 or state securities laws. They may only be offered or sold in the United States under an applicable registration exemption.
Did HCA (HCA) change any other terms of its commercial paper program?
The company states that other terms and conditions remain as previously described in its earlier disclosure. The only change highlighted is the increase in the maximum aggregate face or principal amount outstanding from $4.0 billion to $8.0 billion.